BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang B, Liang L, Chen W, Liang C, Zhang S. An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis. PLoS One 2015;10:e0129720. [PMID: 26076348 DOI: 10.1371/journal.pone.0129720] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Lunyera J, Mohottige D, Alexopoulos AS, Campbell H, Cameron CB, Sagalla N, Amrhein TJ, Crowley MJ, Dietch JR, Gordon AM, Kosinski AS, Cantrell S, Williams JW Jr, Gierisch JM, Ear B, Goldstein KM. Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review. Ann Intern Med 2020;173:110-9. [PMID: 32568573 DOI: 10.7326/M20-0299] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69:e71-e126. [PMID: 27851992 DOI: 10.1016/j.jacc.2016.11.007] [Cited by in Crossref: 235] [Cited by in F6Publishing: 199] [Article Influence: 78.3] [Reference Citation Analysis]
3 Martí-bonmatí L, Martí-bonmatí E. Retención de compuestos de gadolinio usados en resonancia magnética: revisión crítica y recomendaciones de las agencias regulatorias. Radiología 2017;59:469-77. [DOI: 10.1016/j.rx.2017.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
4 Tummala S, Scherbel D. Clinical Assessment of Peripheral Arterial Disease in the Office: What Do the Guidelines Say? Semin Intervent Radiol 2018;35:365-77. [PMID: 30728652 DOI: 10.1055/s-0038-1676453] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
5 Radovic N, Ivanac G, Divjak E, Biondic I, Bulum A, Brkljacic B. Evaluation of Breast Cancer Morphology Using Diffusion-Weighted and Dynamic Contrast-Enhanced MRI: Intermethod and Interobserver Agreement. J Magn Reson Imaging 2019;49:1381-90. [PMID: 30325549 DOI: 10.1002/jmri.26332] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
6 Krishnamurthy R, Bahouth SM, Muthupillai R. 4D Contrast-enhanced MR Angiography with the Keyhole Technique in Children: Technique and Clinical Applications. RadioGraphics 2016;36:523-37. [DOI: 10.1148/rg.2016150106] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
7 Kay FU, Pedrosa I. Imaging of Solid Renal Masses. Urol Clin North Am 2018;45:311-30. [PMID: 30031457 DOI: 10.1016/j.ucl.2018.03.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
8 Mackay DD, Takacs SM. Central Venous Obstruction-Induced Intracranial Hypertension in Hemodialysis Patients: An Underrecognized Cause of Elevated Intracranial Pressure. J Neuroophthalmol 2020;40:218-25. [PMID: 32392024 DOI: 10.1097/WNO.0000000000000964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nishiyama KH, Saboo SS, Tanabe Y, Jasinowodolinski D, Landay MJ, Kay FU. Chronic pulmonary embolism: diagnosis. Cardiovasc Diagn Ther 2018;8:253-71. [PMID: 30057874 DOI: 10.21037/cdt.2018.01.09] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
10 Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135:e726-79. [PMID: 27840333 DOI: 10.1161/CIR.0000000000000471] [Cited by in Crossref: 177] [Cited by in F6Publishing: 165] [Article Influence: 29.5] [Reference Citation Analysis]
11 Woolen SA, Shankar PR, Gagnier JJ, MacEachern MP, Singer L, Davenport MS. Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis. JAMA Intern Med 2020;180:223-30. [PMID: 31816007 DOI: 10.1001/jamainternmed.2019.5284] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 31.0] [Reference Citation Analysis]
12 Caruana G, Pessini LM, Cannella R, Salvaggio G, de Barros A, Salerno A, Auger C, Rovira À. Texture analysis in susceptibility-weighted imaging may be useful to differentiate acute from chronic multiple sclerosis lesions. Eur Radiol 2020;30:6348-56. [PMID: 32535736 DOI: 10.1007/s00330-020-06995-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Romero CA, Cabral G, Knight RA, Ding G, Peterson EL, Carretero OA. Noninvasive measurement of renal blood flow by magnetic resonance imaging in rats. Am J Physiol Renal Physiol 2018;314:F99-F106. [PMID: 28978533 DOI: 10.1152/ajprenal.00332.2017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
14 Elizalde-González MP, García-Díaz E, González-Perea M, Mattusch J. Removal of gadolinium-based contrast agents: adsorption on activated carbon. Environ Sci Pollut Res Int 2017;24:8164-75. [PMID: 28144867 DOI: 10.1007/s11356-017-8491-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
15 Hakozaki Y, Uchiyama K, Yanai A, Yamada D, Kamijo Y, Ishibashi Y. Sarcomatoid renal cell carcinoma with autosomal dominant polycystic kidney disease: a case report and literature review. CEN Case Rep 2021;10:199-207. [PMID: 33064294 DOI: 10.1007/s13730-020-00544-z] [Reference Citation Analysis]
16 Pozzi-Mucelli RM, Rinta-Kiikka I, Wünsche K, Laukkarinen J, Labori KJ, Ånonsen K, Verbeke C, Del Chiaro M, Kartalis N. Pancreatic MRI for the surveillance of cystic neoplasms: comparison of a short with a comprehensive imaging protocol. Eur Radiol 2017;27:41-50. [PMID: 27246720 DOI: 10.1007/s00330-016-4377-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
17 Martin DR, Kalb B, Mittal A, Salman K, Vedantham S, Mittal PK. No Incidence of Nephrogenic Systemic Fibrosis after Gadobenate Dimeglumine Administration in Patients Undergoing Dialysis or Those with Severe Chronic Kidney Disease. Radiology 2018;286:113-9. [DOI: 10.1148/radiol.2017170102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
18 Tasker F, Fleming H, Mcneill G, Creamer D, Walsh S. Contrast media and cutaneous reactions. Part 1. Immediate hypersensitivity reactions to contrast media and gadolinium deposition. Clin Exp Dermatol 2019;44:839-43. [DOI: 10.1111/ced.13990] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Batra K, Chamarthy M, Chate RC, Jordan K, Kay FU. Pulmonary vasculitis: diagnosis and endovascular therapy. Cardiovasc Diagn Ther 2018;8:297-315. [PMID: 30057877 DOI: 10.21037/cdt.2017.12.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Bak SH, Roh HG, Moon WJ, Choi JW, An HS. Appropriate Minimal Dose of Gadobutrol for 3D Time-Resolved MRA of the Supra-Aortic Arteries: Comparison with Conventional Single-Phase High-Resolution 3D Contrast-Enhanced MRA. AJNR Am J Neuroradiol 2017;38:1383-90. [PMID: 28473338 DOI: 10.3174/ajnr.A5176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
21 Liu C, Li M, Xiao H, Li T, Li W, Zhang J, Teng X, Cai J. Advances in MRI‐guided precision radiotherapy. Precision Radiation Oncology. [DOI: 10.1002/pro6.1143] [Reference Citation Analysis]